Medifast announces new scientific advisory board appointments

Expansion of expert panel builds on company's strong scientific heritage as it sets sights on broader $230 billion health and wellness industry baltimore , july 21, 2022 /prnewswire/ -- medifast (nyse: med), the global company behind one of the fastest-growing health and wellness communities, opta via ®, announced today the addition of three new members to its long-standing scientific advisory board: dr. nikhil dhurandhar, dr. graham thomas and dr. jessica unick. medifast's scientific advisory board is now comprised of seven internationally recognized experts who provide objective insights to guide the company in making informed decisions based on the latest scientific developments in health and wellness.
MED Ratings Summary
MED Quant Ranking